Thank you

This live web event has ended. Thank you for attending.

Description

Universal Testing for
HRD in Ovarian Cancer:
A Pathologist's Perspective

Why should you register now for this webinar?

• Learn the role of homologous recombination deficiency
  (HRD) in the development of ovarian cancer
• Explore the rationale for expanded biomarker testing in
  advanced ovarian cancer
  
• Discuss strategies to maximize testing efficiency with
  pathologist-initiated testing